Research Tools and Online Resources
Discover helpful tools for advancing your rare and orphan disease research.
Rare and orphan diseases affect fewer than 200,000 individuals in the United States, and nearly 700,000 rare diseases have been described to date. The Jackson Laboratory offers the world's largest collection of spontaneous, targeted, and transgenic mutant mouse strains, hundreds of which model rare diseases.
Discover helpful tools for advancing your rare and orphan disease research.
The Rare and Orphan Disease Center brings together global mouse resources and the expertise of scientists at the Jackson Laboratory for a start-to-finish approach to model development.
In honor for International Myotonic Dystrophy Awareness Day 2021, JAX's Laurent Bogdanik discusses the disease and potential...
What is a mouse model? Find out in this Minute to Understanding from the Jackson Laboratory!
With leading scientists, international networking, precision animal models, and next-generation genetics and genomics technologies, The...
Resources for people who are interested in learning more about rare diseases, clinical trials, and research programs.
Rare and Orphan Disease Research Tools and Online Resources
Rare disease families and experts offer advice on how to navigate the rare disease odyssey.
Families have banded together from across the globe to make awareness and research for SMARD a reality.
Using the right mouse model can reveal various biological intricacies and may lead to potential therapeutic treatments. In a recent study,...
Efficacy studies are performed by JAX on mouse models for these diseases: C57BL10.mdx and D2.mdx for DMD, DyW for CMD1A, and A/J for...
JAX distributes well-characterized, preclinical mouse models to accelerate drug discovery for rare and orphan diseases.
We partner with foundations, pharmaceutical and biotech companies, and other scientists to research treatments for uncommon...
Did you know that almost all of us have the sort of genetic mutations that cause rare genetic diseases?
JAX Professor Robert Burgess and collaborators are developing personalized gene therapy for a Texas child suffering from a neuromuscular...
Genetic diversity should be accounted for in pre-clinical tests, and researchers need to select the right model system to mimic human...
What should healthcare professionals do to incorporate genomic medicine into patient care? Here are the keys to genomic risk...
JAX has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the...
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.